| Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase KT Hastings, P Cresswell Antioxidants & redox signaling 15 (3), 657-668, 2011 | 102 | 2011 |
| Molecular Basis for Leukocyte Integrin αEβ7 Adhesion to Epithelial (E)-Cadherin KS Taraszka, JMG Higgins, K Tan, DA Mandelbrot, J Wang, MB Brenner The Journal of experimental medicine 191 (9), 1555-1567, 2000 | 84 | 2000 |
| Diverse cellular and organismal functions of the lysosomal thiol reductase GILT MP Rausch, KT Hastings Molecular immunology 68 (2), 124-128, 2015 | 77 | 2015 |
| Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing KT Hastings, RL Lackman, P Cresswell The Journal of Immunology 177 (12), 8569-8577, 2006 | 72 | 2006 |
| Immune checkpoint inhibitors in the treatment of melanoma: from basic science to clinical application MP Rausch, KT Hastings Cutaneous Melanoma: Etiology and Therapy [Internet], 2017 | 59 | 2017 |
| Low GILT expression is associated with poor patient survival in diffuse large B-cell lymphoma H Phipps-Yonas, H Cui, N Sebastiao, PS Brunhoeber, E Haddock, ... Frontiers in immunology 4, 425, 2013 | 58 | 2013 |
| GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1 MP Rausch, KR Irvine, PA Antony, NP Restifo, P Cresswell, KT Hastings The Journal of Immunology 185 (5), 2828-2835, 2010 | 57 | 2010 |
| Fundamentals of cancer prevention D Alberts, LM Hess Springer Science & Business Media, 2013 | 55 | 2013 |
| Identification of structural markers for vitamin B12 and other corrinoid derivatives in solution using FTIR spectroscopy KS Taraszka, E Chen, T Metzger, MR Chance Biochemistry 30 (5), 1222-1227, 1991 | 42 | 1991 |
| GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1 MP Rausch, KT Hastings Journal of investigative dermatology 132 (1), 154-162, 2012 | 37 | 2012 |
| Cancer neoantigens: challenges and future directions for prediction, prioritization, and validation ES Borden, KH Buetow, MA Wilson, KT Hastings Frontiers in Oncology 12, 836821, 2022 | 35 | 2022 |
| GILT: Shaping the MHC class II-restricted peptidome and CD4+ T cell-mediated immunity KT Hastings Frontiers in immunology 4, 429, 2013 | 33 | 2013 |
| Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis SM Chavel, KS Taraszka, JV Schaffer, R Lazova, JS Schechner Journal of the American Academy of Dermatology 50 (5), 125-128, 2004 | 30 | 2004 |
| GILT expression in B cells diminishes cathepsin S steady‐state protein expression and activity H Phipps‐Yonas, V Semik, KT Hastings European journal of immunology 43 (1), 65-74, 2013 | 28 | 2013 |
| High GILT expression and an active and intact MHC class II antigen presentation pathway are associated with improved survival in melanoma KH Buetow, LR Meador, H Menon, YK Lu, J Brill, H Cui, DJ Roe, ... The Journal of Immunology 203 (10), 2577-2587, 2019 | 23 | 2019 |
| Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma J Nguyen, R Bernert, K In, P Kang, N Sebastiao, C Hu, KT Hastings Melanoma research 26 (2), 125-137, 2016 | 20 | 2016 |
| An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen MP Rausch, KT Hastings PloS one 10 (4), e0123332, 2015 | 18 | 2015 |
| The Lymphoid Neoplasms 3ed I Magrath CRC Press, 2010 | 17 | 2010 |
| Shared gene expression and immune pathway changes associated with progression from nevi to melanoma ES Borden, AC Adams, KH Buetow, MA Wilson, JE Bauman, ... Cancers 14 (1), 3, 2021 | 12 | 2021 |
| Neoantigen fitness model predicts lower immune recognition of cutaneous squamous cell carcinomas than actinic keratoses ES Borden, P Kang, HM Natri, TN Phung, MA Wilson, KH Buetow, ... Frontiers in immunology 10, 2799, 2019 | 11 | 2019 |
Matthew RauschSurface OncologyVerified email at surfaceoncology.com
